GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » ROE % Adjusted to Book Value

Medical Developments International (ASX:MVP) ROE % Adjusted to Book Value : 1.46% (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medical Developments International ROE % Adjusted to Book Value?

Medical Developments International's ROE % for the quarter that ended in Dec. 2024 was 1.20%. Medical Developments International's PB Ratio for the quarter that ended in Dec. 2024 was 0.82. Medical Developments International's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 1.46%.

Medical Developments International ROE % Adjusted to Book Value Historical Data

The historical data trend for Medical Developments International's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Developments International ROE % Adjusted to Book Value Chart

Medical Developments International Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 -4.80 -10.86 -9.87 -84.91

Medical Developments International Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.03 -23.77 -32.05 -130.24 1.46

Competitive Comparison of Medical Developments International's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medical Developments International's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Medical Developments International's ROE % Adjusted to Book Value falls into.


;
;

Medical Developments International ROE % Adjusted to Book Value Calculation

Medical Developments International's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-64.53% / 0.76
=-84.91%

Medical Developments International's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=1.20% / 0.82
=1.46%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Medical Developments International's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Medical Developments International Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medical Developments International Ltd (ASX:MVP) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
ASX:VIT ASX:IDT ASX:LGP ASX:NXS ASX:ECS ASX:VLS ASX:CAN ASX:PER ASX:AGH ASX:RGT ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
MDDVF:USA
Address
4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Website
https://www.medicaldev.com
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.

Medical Developments International Headlines

From GuruFocus

Medical Developments International Stock Appears To Be Possible Value Trap

By GF Value • 01-01-1970

Roundhill Announces Two Fund Closures

By PRNewswire PRNewswire • 03-18-2022